Skip to content

Clinical trials

Phase 2 Hypertension, Pulmonary trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension, Pulmonary Phase: Phase 2 Country / region: United Kingdom Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20103
20111
20171
20182
20191
20212
20223
20233
20241
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated11
Completed6
Active, not recruiting4
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Bayer2
Complexa, Inc.2
Merck Sharp & Dohme LLC2
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA1
Actelion1
Apollo Therapeutics Ltd1
AstraZeneca1
Gilead Sciences1
Heidelberg University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension, Pulmonary23
Pulmonary Arterial Hypertension9
Cardiovascular Diseases3
Familial Primary Pulmonary Hypertension3
Hypertension3
Lung Diseases3
Vascular Diseases3
Connective Tissue Diseases2
Cough2
Dizziness2

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.